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A cost utility analysis of the clinical algorithm for nasogastric tube placement confirmation in adult 
hospital patients 
Abstract 
Aim: To evaluate the effectiveness of pH paper testing of aspirate and chest x-ray for determining 
nasogastric tube placement in terms of cost and patient outcome.  
Background: Nasogastric tubes are frequently used in clinical practice, however during insertion the 
practitioner is blinded as to the precise final location of the passed tube. Despite robust checking 
procedures, recognised patient morbidity and mortality associated with this procedure have 
resulted in recent national safety alerts prompting the revision of all clinical guidelines in relation to 
nasogastric tube care.  
Design: Cost utility analysis using economic modelling.  
Methods: A decision tree was built and populated with effectiveness data gathered from a 
systematic search of the extant literature base. Specificity, pooled sensitivity and event probabilities 
were calculated using statistical software.  Patient outcome was measured in terms of quality of life. 
Health state utilities were gathered from a sample (n=23) of adult surgical patients using a 
recognised instrument. Cost data was gathered using published sources. The study adopted a third 
party payer perspective in a Scottish context.  
Results: The results confirm that the current UK algorithm advocated by the National Patient Safety 
Agency appears to offer the most cost effective approach to NGT confirmation in terms of cost and 
patient outcome. Sensitivity analyses indicate that these findings may be significantly altered by 
tube aspiration success and the rates of chest x-ray interpretation errors. 
Conclusion: The results confirm current UK recommendations and have wider policy implications for 
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Why is this research or review needed? 
 Nasogastric tubes are frequently used in clinical practice but despite the availability of 
robust checking procedures, the procedure is still recognised as a cause of avoidable 
mortality and morbidity. 
 Patient safety alerts have called for the review of all clinical guidelines in relation to 
nasogastric tube care. 
 There is international disparity in the cost and effectiveness trade-off between the two most 
commonly used methods of nasogastric tube confirmation (pH testing and x-ray).  
What are the key findings? 
 Even if no complications occur, nasogastric tube insertion still impacts the patient’s 
perceived health state.  
 Compared to no checking procedure, chest x-ray is a more effective but more expensive 
approach than pH testing of aspirate for nasogastric tube placement confirmation.  
 Using chest x-ray as the first line checking procedure for nasogastric tube placement 
confirmation without testing pH of aspirate significantly increases costs. 
How should the findings be used to influence policy/practice/research/education? 
 Current UK recommendations for nasogastric tube placement confirmation appear to be the 
most cost effective in terms of cost and patient outcome. 
 Wider policy implications are evident for those areas whereby chest x-ray is recommended 
as the first and only acceptable approach to nasogastric tube placement confirmation.  
 
  






Nasogastric tubes (NGT) are widely used within healthcare but carry with them a recognised 
morbidity and mortality risk. Although individual risk is low, given the extent of NGT usage an 
unacceptable amount of patient harm is resultant from these tubes on an annual basis. This finding 
is especially pertinent given that with correct placement confirmation, the entirety of this burden on 
patient harm may be eliminated (Krenitsky 2011). Several placement confirmation methods are 
available but of these only pH testing and chest x-rays are advocated in UK clinical guidelines 
(National Patient Safety Agency (NPSA) 2011a). pH testing may be performed relatively cheaply at 
the bedside but at a lower accuracy than the more expensive chest x-ray method (Ellet 2004). There 
is currently international disparity in the cost and effectiveness trade-off between these two tests, 
however no formal economic evaluation exists in the evidence base. The current study therefore 
attempts to address this knowledge gap. 
Background  
The insertion of a NGT is the passage of a tube, appropriate for its intended purpose, via the nostril 
into the stomach (National Institute for Clinical Excellence 2006). NGTs are used within clinical 
practice for a wide variety of reasons and thus NGT placement is an extremely common clinical 
intervention, with an estimated 170,000 feeding tubes being used annually in the United Kingdom 
alone (Eveleigh 2011).  Although the majority of these tubes are inserted and used without incident, 
there is a recognised risk that the tube can be misplaced into the lungs, or move out of the stomach 
(Burns et al.  2001).  
Confirmation of NGT placement is required immediately following insertion and subsequently prior 
to each use (for example, administration of enteral feed or medication). Additionally, the tube 
should be checked following episodes of vomiting, retching or coughing spasms, after oropharyngeal 
suction has been required or where there is a suggestion of tube displacement. Any new or 
unexplained respiratory symptoms or a drop in oxygen saturation readings is a further indication for 
seeking repeated confirmation of NGT placement (Durai et al.  2009).  
pH testing of gastric aspirate obtained via the NGT is recommended as a first line test method for 
establishing correct position. A pH reading of between 1 – 5.5 is considered a reliable method for 
excluding placement in the pulmonary tree; however is not a definitive confirmation of gastric 
placement. When aspirate is not able to obtained, or first line pH testing is inconclusive, national 
guidelines recommend placement confirmation with a chest x-ray (NPSA 2011b). These tests may 
only be foregone in patients where the placement of the NGT is completed under direct visualisation 
of a surgeon or anaesthetist (for example, patients undergoing gastric surgery or endoscopy 
procedures) (NPSA 2011a).  
Although the majority of these tubes are inserted and used without incident, there is a recognised 
risk that the tube can be misplaced into the lungs, or move out of the stomach. Published reports of 
incidents have included oesophageal, peritoneal and intestinal placement, and NGTs placed within 
the brain (Burns et al.  2001). Additionally, severe pulmonary complications, indeed mortality, have 
been reported as a direct result of NGT placement within the respiratory tract (Miller 2011). 




Between September 2005 and March 2010, 21 deaths and 79 cases of harm relating to feeding 
through misplaced NGTs were reported (NPSA 2011a). Due to these serious consequences, NGT 
misplacement was included as one of the eight ‘Never Events’ identified by the NSPA (2010a).  
Despite this, the second highest reported Never Event in the period between 2009 – 2010 was NGT 
misplacement, with 41 reports of significant patient safety incidents (NPSA 2010b). Additionally, a 
number of these incidents occurred despite the recommended first and second line tests being 
undertaken, with the NPSA directly attributing 45 incidents between 2005 and 2011 to cases of 
misinterpretation (NPSA 2011b).  
With recent national safety alerts prompting the revision of all clinical guidelines in relation to NGT 
care, a formal evaluation which assesses the outcomes of patients in relation to the two currently 
recommended methods is timely and indicated. Clinical guidelines from the United States outline 
that blindly placed NGT placement should always be verified radiologically (Metheny 2009). There is, 
therefore, international disparity in the decision making trade-off between the more efficacious but 
costly chest x-ray alternative against the cheaper but potentially less specific pH testing of aspirate. 
The existence of this disparity demonstrates that robust evaluations of the current methods for NGT 
placement confirmation in terms of both patient outcomes and cost are not yet available. An 
economic evaluation of the currently recommended confirmation algorithm will inform future 
guideline development and has clear policy implications for patient safety on both a national and 
international platform.  
THE STUDY 
Aim/s 
The aim of this research was to evaluate the effectiveness of pH paper testing of aspirate and chest 
x-ray as outlined in the currently recommended NPSA algorithm (NPSA 2011c)  for determining NGT 
placement in terms of cost and patient outcome for adult patients. 
Design 
This study was a cost utility analysis comparing the costs and consequences of using chest x-ray 
versus pH testing of aspirate as first line procedures for checking NGT placement. Consequences 
were measured in terms of quality of life using quality adjusted life years (QALYs).  
The study adopted a third party payer perspective (NHS) based in Scotland. The time horizon was set 
at 6 weeks, in line with the NICE (2006) definition of short term NGT placement and incorporating 
the average length of inpatient hospital stay (4.8 days) in the study setting (ISD Scotland 2012a). 
Given the short time horizon, a 0% discount rate was applied (Husereau et al 2013). 
Sample/Participants 
In order to increase the homogeneity of the patient group and increase the validity of the 
comparison, the patient population inclusion criteria were: 
 adult patients; defined through admission to an adult care area 
 short term NGT placement; defined as up to 6 weeks (NICE 2006) 
 hospital setting 




 receiving general care; defined as no artificial airway insitu  
Data collection  
Measurement of effectiveness 
A systematic search of literature was undertaken using Cochrane Collaboration methodology 
(Higgins & Green 2011). The criteria for considering studies are summarised in Table 1, and a flow 
diagram of the search results is presented in Figure 1.  
A total of three studies were included in the synthesis for chest x-ray effectiveness (Gharemani and 
Gould 1986, Sorokin and Gootlieb 2006, de Aguilar-Nascimento and Kudsk 2007). Details of the 
complications were assessed individually and grouped according to the criteria where Low Harm was 
indicated by no additional treatment required and no delay in discharge, Moderate Harm requiring 
some additional treatment within the same care area and a slight delay in discharge and Severe 
Harm as requiring additional extensive treatment with care in a higher dependent area (such as HDU 
or ITU) and a significant delay in discharge home. A summary of the data is provided in Table 2. 
No single studies were available which evaluated the performance of pH testing in relation to 
specific complication rates and patient outcomes, therefore the effectiveness data were calculated 
using a two stage approach. Initially to calculate effectiveness, a total of three studies were 
identified (Metheny et al 1999, Metheny, Smith and Stuart 2000, Kearns and Donna 2001)and data 
were extracted and used to construct 2 x 2 tables of true positive, false positive, true negative and 
false negative cases for each. All data were classified as binary (either gastric placement, or not) 
therefore no threshold for test positivity was required (Deeks et al 2010). Sensitivity, specificity and 
a 95% CI for each study were then calculated using RevMan 5.2 software (The Nordic Cochrane 
Centre, The Cochrane Collaboration 2012). Finally, these data were combined in meta-analysis using 
Meta-DiSc 1.4 software (Zamora et al 2006) to calculate the pooled sensitivity of pH testing  across 
the three studies (sensitivity 0.823, CI 0.803 – 0.843).  
A further three studies (Metheny et al 1989, Welch et al 1994, Neumann, Meyer and Dutton 1995) 
were added to two from the meta-analysis to calculate the probability of obtaining aspirate from the 
NGT (Table 3). The study by Metheny, Smith and Stewart (2000) was excluded from this calculation 
as data were reported on aspirate pH ability to detect correct NGT placement, not the ability to 
obtain aspirate for testing. All possible outcomes were assumed equally likely and therefore 
probability was calculated by dividing the number of instances of aspiration success by the total 
number of attempts. Finally, probability weights for complication incidence were calculated from 
published NRLS patient safety incident report data  (NPSA 2008) with the levels of complication 
calculated from narratives of these incidents provided in Hannah et al ’s (2010) NHS report into 
improving NGT safety. Overall probability of complications was calculated as per aspiration success. 
The number of complications was used as the denominator when calculating probability weights for 
each level of harm.  
 Measurement and valuation of preference based outcomes 
Utility values for health states were sought in which following NGT placement confirmation no 
complications, mild, moderate and severe complications were encountered. As none were available 
in the existing literature, these were gathered directly from patients. A sample of 31 patients 




admitted to an acute surgical unit were provided with four vignettes of the health states under 
consideration and asked to value each one using the EQ-5D instrument (The EuroQol Group 1990). 
The vignettes described four scenarios involving NGT insertion and checking, ranging from a simple 
insertion and check with no complications to an NGT insertion that resulted in significant, severe 
complications which required intervention and an extended hospital stay. The vignettes were based 
on actual NGT placement related adverse events reported by Hannah et al (2010) and were 
supported by a patient information sheet including details of the clinical indication of a NGT and the 
checking procedures. Participants were asked to imagine they were the patient described in the 
scenario and rate the impact of the hypothetical events on their health and wellbeing using the 
scoring tools in the EQ-5D.  
Seven patients declined participation; one agreed but did not complete the documentation resulting 
in a final sample of 23. The EQ-5D was self-administered and completed anonymously.  
The ratings for each health state were converted using the EQ-5D-5L Value Sets Crosswalk Index 
Value Calculator and also calculated using the visual analogue scale (VAS) scores. The 
recommendations of Dolan (2000) were used to aggregate the valuations for each health state, with 
the skewed distribution (for all health state valuations expect Moderate Complications) guiding the 
choice of median (with 25th and 75th percentiles) over mean for QALY calculations.  
 Estimating resources and costs 
Cost data utilised current NHS prices in relation to consumables and investigation costs. Staff costs in 
terms of time were calculated using the midpoint of the NHS pay scale for all relevant staff members 
required. Oncosts were considered in accordance with the perspective of the study. Costs for 
repeated chest x-ray placement confirmation when first attempt failed were calculated in terms of 
marginal costs. Given 6 week NHS usage of NGT of 31269 tubes (NPSA 2008) and a failure to confirm 
rate of 6% (Rollins et al 2012) a maximum of 3 repeats (in addition to the original x-ray) were 
calculated and costed accordingly. Summary estimates of costs are outlined in Table 4.  
Ethical considerations 
Ethical approval was sought from the local NHS ethics committee for the valuation of preference 
based outcomes but was deemed not necessary due to the nature of the information sought.  The 
project was considered a service evaluation.  
Data analysis 
All data were analysed using a decision tree model built using TreeAge Pro Healthcare software 
(TreeAge Software Inc 2013). The model structure and all study parameters entered can be seen in 
Figure 2.  
Validity and reliability/ Rigour 
The model required a number of assumptions. As the time horizon was set at 0.125 years, no 
discounting was applied. The baseline patient characteristics were adult surgical patients with no 
artificial airway insitu and not nursed in a low to medium dependency area. The model assumes one 
NGT per patient over the time horizon of the study. Efficacy of each method (pH testing and chest x-




ray) was expressed in terms of probability of complication and level of complication, with the ability 
to confirm NGT position per x-ray set at 94% (failure rate of 6%) and ability to obtain aspirate for pH 
testing set at 87% (failure rate of 13%). If the NGT position was not confirmed within 2 x-rays, the 
model assumes that the checking procedure would be abandoned.  
In terms of cost inputs, radiology staff costs were incorporated into the costs of the x-ray, with 
interpretation costs separate. Low complications assumed no additional treatment was required, 
moderate complications required additional ward bed days, chest drain insertion and additional care 
and severe complications required intensive care. Only the costs of the confirmation method were 
used for the Death health state outcome.  
In terms of utility inputs, the model assumed that these would be the same for each health state 
outcome, regardless of checking procedure. Where the checking procedure is abandoned (i.e. when 
no method can confirm placement), no utility is gained.  
Base case assumptions and parameter uncertainties were explored using one way deterministic 
sensitivity analysis.  
RESULTS 
Utility of NGT placement and subsequent complications 
The EQ-5D instrument was completed anonymously; therefore no sample characteristics are 
available to report. Given the nature of the care area (an adult surgical unit), it can be assumed that 
all participants were over 16 years of age.  
Despite experiencing no complications, the insertion of an NGT still resulted in a slight dip in health, 
as rated by the 23 participants. As expected, the utility values decrease as the severity of 
complications with NGT placement increase. The mean and median values remain similar using the 
VAS utility values, contrasted with those obtained from the index ratings. Overall, utility ratings for 
all health states were higher using the VAS part of the EQ-5D instrument with the most noticeable 
difference in Severe Complications health state. See Table 4 for a summary.  
Cost utility 
The base case is compared to no checking procedure and thus zero utility attributed to a non-
functioning NGT. Each checking procedure was considered in turn as the base case (pH testing and 
chest x-ray).Compared to no checking procedure, chest x-ray delivers a higher QALY gain than pH 
testing when compared no checking procedure (0.12 QALYs vs. 0.11 QALYs) but also at higher cost 
(x-ray costs £1322.00 per QALY gained, pH testing £392.73 per QALY gained).  If the base case is 
altered to pH testing, the cost effectiveness in terms incremental cost effectiveness ratio (ICER) for 
chest x-ray rises significantly. Compared to no checking procedure, the cost per QALY of checking 
NGT position by x-ray alone without attempting aspiration for pH testing first is £11544.   
Sensitivity analysis  
Aspiration success has considerable impact on the ICER of pH testing, with lower success rates 
resulting in a 22% increase from the base case. pH confirmation success rate had only marginal 
impact, which appears logical given the narrow confidence interval range. Upper and lower bound 




chest x-ray complication rates also resulted in significant alterations to the base case ICER. Again, 
this appears logical given that chest x-ray is the “back up” confirmation method when aspiration or 
pH testing confirmation fails. Using VAS utility values results in a 10% increase in ICER, a result driven 
by the higher health state valuations using this instrument of the EQ-5D tool. When the cost of 
Death health state is considered to equal that of Severe Complications, an increase of 29% is noted 
from the pH base case ICER. 
Upper and lower bound chest x-ray complication rates also greatly impact the chest x-ray ICER. 
Lower complication rates result in an ICER decrease of 19.5%. Again, the higher VAS health state 
valuations impacted on the ICER (around a 10% increase) and the impact of the increased cost of 
Death health state resulted in a 33% increase in ICER, slightly more than the increase noted for pH 
testing in the same analysis. A summary of the base case cost utility results and sensitivity analyses 
can be found in Table 5.  
DISCUSSION  
NGT placement is an extremely common clinical intervention with the majority of tubes passed 
without complication. However there is a recognised risk that during the procedure, because the 
practitioner is blinded to the final placement, the NGT may be misplaced into the lungs. Placement 
confirmation methods are therefore required and currently, pH testing of aspirate and chest x-ray is 
recommended in UK national guidelines (NPSA 2011c) although international disparity exists on best 
practice recommendations (Metheny 2009). Additionally, no previous economic evaluation has been 
completed which compares the two currently recommended confirmation methods.  
Clinical outcome was measured through QALY gains, adjusted to the 0.125 year timeline of the 
study. In terms of effectiveness, both pH testing and chest x-ray produce QALY gains when 
compared to no checking procedure. Chest x-ray produces a slightly higher QALY (0.01) than pH 
testing. In terms of cost, compared to a base case of no confirmation procedure, the incremental 
cost of pH testing is £43.20 which is significantly lower than the £158.64 of chest x-ray. This results in 
an ICER for pH testing of £392.73 per QALY, over a third lower than chest x-ray (ICER £1322 per 
QALY). When compared to a base case of pH testing, foregoing any attempt to aspirate the NGT in 
the first instance, the costs of chest x-ray as first line confirmation results in a significantly higher 
ICER of £11544 per QALY gained. This appears logical given that chest x-ray confirmation offers only 
a 0.01 QALY gain over pH testing as a first line attempt. As no previous work has evaluated the cost 
effectiveness of the NGT checking procedure, a comparison to other published work as 
recommended by Phillips et al (2004) is not possible.  
 
The current UK algorithm advocated by the NPSA (2011c) therefore appears to offer the most cost 
effective approach to NGT confirmation in terms of QALYs gained. However, the results of the 
sensitivity analysis indicate that these findings may be significantly altered by NGT aspiration success 
and the rates of chest x-ray interpretation errors. The ability of obtaining aspirate from a NGT for pH 
testing may be influenced by a number of factors. Smaller bore feeding tubes are more liable to 
collapse when negative pressure is applied (Crocker et al 1981), with Silk et al (1987) also finding 
that changing the material of the tube itself (from polyvinyl chloride to polyurethane) leads to 
significant (p < 0.001) increases in aspiration attempt success. It should be noted that the probability 
of obtaining aspirate for the current study was calculated at 0.87 from five studies identified as part 




of the systematic literature search, with two studies from Metheny et al (1989, 1999). Norma 
Metheny is extensively published in the field of NGT care and is considered an expert in the field. 
Indeed, she has published specific guidelines on how to maximise aspiration success of NGTs 
(Metheny et al 1993). The two studies from Metheny et al (1989, 1999) contributed to over half of 
the data (57%) for the estimation of aspiration success for this current work and therefore may have 
increased the estimate to above what may be achieved by non-experts in the field. Sensitivity 
analysis was utilised using a range of aspiration success rates to explore this impact on the study 
ICER estimate. Similarly, in a systematic review by Sparks et al. (2011) clinician experience in x-ray 
interpretation was found to impact on the rate of complications encountered. Estimation of 
complication rates for chest x-ray in the current study was generated using observational data and 
therefore should better reflect the heterogeneity of clinicians’ interpretation abilities in actual 
clinical practice (Black 1999). Sensitivity analyses facilitated a further exploration of the impact of 
this potential variable on the study ICER estimates. However, it should be noted that strategies to 
improve chest x-ray interpretation for NGT placement confirmation (and thus lower complication 
rates) such as the training tool described by Eveleigh et al (2011) also carry a cost which may offset 
any savings gained. If such strategies are utilised then the additional cost of training needs to be 
considered in any future economic evaluation, particularly if the third party payer perspective is 
maintained.  
Alterations in the base case resulted in significant increases in the cost per QALY gained. This finding 
has particular relevance to international clinical policy comparisons. The model for the current work 
mirrors the current UK NGT placement confirmation algorithm advocated by the NPSA (2011c), 
whereby first line checking should begin with attempt at aspiration for pH testing before proceeding 
to chest x-ray. However, new clinical guidelines endorsed by professional bodies in the USA, Canada 
and Europe state that “every patient should undergo radiography to confirm proper position of an 
NG or OG tube before feeding is initiated” (Itkin et al 2011, p746). The study model demonstrates 
that foregoing pH testing as a first line method of NGT placement confirmation results in an increase 
in cost per QALY gained of £10222. Even accounting for the potential lack of precision of pH testing 
and subsequent possible complications, it appears that utilising this cheap (incremental cost of 
£4.40) bedside test as a first line method offers a more cost effective approach to NGT placement 
confirmation in terms of cost per QALY gained. This is particularly significant when considered in 
light of the frequency of the NGT placement confirmation procedure, estimated by Krenitsky (2011) 
to be 1.2 million annually in the USA alone. 
The current study setting was the Scottish NHS and a third party payer perspective was adopted. 
Since the passing of the Scotland Act (Great Britain Parliament 1998) the powers to run the NHS in 
Scotland have been devolved to the Scottish Government. As a result, NHS Scotland displays some 
systemic differences to that of NHS England and Wales. One of these differences is the Never Event 
framework (Department of Health 2011). This list of 25 preventable events carries a financial penalty 
for the provider if they occur, with a £10,000 payment levied on top of the recovery of costs of care 
and procedures to date should a death occur (NPSA 2010a). To enable extrapolation of the study 
results to the wider UK perspective, the cost of a never event due to misplaced NGT (£10,000 plus 
costs of Severe Complications health state) was added to the model. The resultant incremental costs 
are an increase of £19.74 for pH testing and £82.74 for chest x-ray compared to the Scottish NHS 
base case for the same QALY gains. Consequently the ICERs are also increased by 46% and 52% for 
pH testing and chest x-ray respectively. pH testing therefore still remains the most cost effective 




option in terms of incremental cost and QALYs gained when compared to no checking, therefore the 
national NPSA algorithm (2011c) is correctly used throughout the UK. However, it should be noted 
that the cost of obtaining QALY gains through NGT placement confirmation in the NHS England and 
Wales context is considerably higher than in NHS Scotland. This result is driven purely by the policy 
differences between the two bodies. 
Limitations  
The generalisability of the study results are limited to the base case patient demographic and setting 
(i.e. adult surgical patients with no airway insitu receiving general ward based care). A number of 
factors are known to increase the incidence of complications with NGT placement such as age, with 
paediatric populations at higher risk than adults (Ellet et al 1998). Additionally, bronchial placement 
of NGTs is more prevalent amongst patients with reduced conscious levels or those receiving 
mechanical ventilation (Stroud et al 2003). As such, the findings from this study would represent an 
underestimate if applied to these high risk groups. However, as heterogeneity is known to impact on 
both costs and effectiveness (Coyle et al 2003), it would not have been appropriate to include both 
high and normal risk groups here for the comparison under study. The economic model structure 
accurately mirrors the current NPSA algorithm (NPSA 2011c) and therefore could be easily used and 
updated with data for various subgroups to gain ICER estimates for the NGT placement confirmation 
procedure across a variety of risk profiles.  
There was an acknowledged lack of data pertaining to the specific study setting (Scotland) and as a 
result data from other areas of the UK were used. Although this may influence the study results, 
where possible NHS based information was utilised to minimise the impact of this potential bias. 
Additionally, a reliance on published data for a variety of model inputs (for example, complication 
rates and outcomes) may impact the study results through publication bias (Easterbrook et al 1991). 
An attempt to minimise this impact was undertaken through a systematic approach to literature 
searching and extending the search to include grey literature. Additionally, the UK NHS perspective 
may limit the transferability of the study findings to international settings. However, given the 
results of the sensitivity analysis it would be anticipated that similar results would be generated in 
other health care systems whereby pH testing was associated with lower costs when compared to 
the chest x-ray  checking procedure.  
In line with recommendations of Brazier et al (2005) and Ubel et al (2003) that those patients who 
are experiencing the health state are best place to value them, the study results would have been 
enhanced if valuations were gathered from patients who had actually underwent NGT placement 
confirmation and subsequent complications (or not). The EQ-5D questionnaire was delivered as a 
self-completion questionnaire in line with the intended design of the instrument (Rabin et al 2011). 
However, this also prevented the patients from clarifying any misunderstanding they may have had 
in completing the health state valuations. The presence of misunderstanding or unfamiliarity with 
the EQ-5D instrument is suspected due to a number of anomalous ratings (for example, Moderate 
Complications Health State being rated considerably higher at 0.877 than No Complications Health 
State at 0.143 by one participant)and the extremely low overall combined utility score of Severe 
Complications Health State at 0.036. In practical terms, this means that participants valued Severe 
Complications as being very near 0, the score representing death on the EQ-5D instrument. 
Additionally, gaining access to actual patient data pertaining to complication rates and outcomes in 
terms of additional care required would have facilitated a more accurate representation than the 




current literature based approach. Currently, the study assumes a set profile of care for each level of 
complication, with a specific focus on bronchopulmonary complications as these are the most 
common (Sparks et al 2011). However, single case studies are available which report on a wider 
variety of complications (for example, Pandey et al 2004). Although these are extremely rare their 
inclusion may impact on the current study estimates. By accessing actual patient level data, this 
limitation to the current study may be addressed.  
A final consideration is the sample size of 23 for health state valuations. Although debate exists in 
the literature regarding optimal sample size calculations for cost effectiveness analyses (Briggs & 
Gray 1998, Laska et al  1999), a larger sample size for this current work would have potentially 
provided a more accurate estimate of health state valuations with smaller SEs than the current 
sample.  
CONCLUSION  
The aim of the current study was to evaluate the effectiveness of pH paper testing of aspirate and 
chest x-ray as outlined in the currently recommended NPSA algorithm (NPSA 2011c)  for determining 
NGT placement in terms of cost and patient outcome for adult patients. Using economic modelling, 
an ICER was calculated in terms of costs of checking and subsequent complications and QALY gains. 
The study adopted a third party payer perspective (NHS) in a Scottish setting. The time horizon for 
the study was 0.125 years in line with the recommendations for duration of short term NGT use and 
incorporating average length of stay for the population under consideration (hospitalised adult 
patients in Scotland). Patient outcome was measured in terms of QALYs gained. QALY values were 
obtained using a generic validated questionnaire and calculated for the 0.125 year time horizon. A 
systematic search of the literature was conducted to source effectiveness data and probability rates 
for complications and consequences. Sensitivity analysis was conducted to test the final model 
assumptions and uncertainties around the model inputs. Although the success of aspiration 
attempts and chest x-ray interpretation accuracy were found to significantly alter the ICER 
estimates, the current recommendation of pH testing of aspirate as a first line approach for the 
confirmation of NGT placement remains the most cost effective method in terms of cost and patient 
outcome (measured through QALY gains). The results confirm current UK recommendations from 
the NPSA (2011c) and may have wider policy implications for those areas whereby chest x-ray is 
recommended as the first and only acceptable confirmation approach. 
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1. Medline:    91 
2. Embase:   79 
3. CINAHL:   121 
4. JBI EBP:   5 
Grey literature: 
1. Conference proceedings 0 
2. Reference lists  12 
27 potentially relevant studies  
281 excluded based on abstract and 
title review  
Full text review of 27 potentially 
relevant studies  18 excluded: 
4. Patients all had artificial airway 
insitu (4 studies) 
5. Study not reported in enough 
detail to determine balance of 
artificial airway/not (2 studies) 
6. Lack of raw data and 
inconsistency of results (2 
studies) 
7. No chest x-ray comparison (1 
study) 
8. Review or audit articles, not 
primary research data (9 studies) 
6 included in synthesis: 
1. X-ray:   3 
2. pH testing:   3 
3. Ability to obtain aspirate: 3 





A patient who is currently in hospital for surgery who is otherwise fit and well. 
They have a nasogastric tube inserted and the position is checked according to the current clinical 
guidelines. 
No complications arise and no treatment is required as a result of the nasogastric tube 
 
A patient who is currently in hospital for surgery who is otherwise fit and well. 
They have a nasogastric tube inserted and the position is checked according to the current clinical 
guidelines. 
Some complications arise as a result of the nasogastric tube insertion. The patient experiences 
some harm from this but it is considered a low amount. No additional treatment is required. 
They are fully mobile and in some minor pain from the nasogastric tube.  
Discharge home will not be delayed. 
 
A patient who is currently in hospital for surgery who is otherwise fit and well. 
They have a nasogastric tube inserted and the position is checked according to the current clinical 
guidelines. 
Some major complications arise as a result of the nasogastric tube insertion. The patient 
experiences harm from this and it is considered a moderate amount. Additional treatment is 
required but they are cared for in the same ward. Their condition deteriorates but is treated 
successfully.  
Their mobility is limited as a result of these events and they require help to wash, dress and go to 
the toilet.  
Discharge home will be delayed, but not significantly. 
 
A patient who is currently in hospital for surgery who is otherwise fit and well. 
They have a nasogastric tube inserted and the position is checked according to the current clinical 
guidelines. 
Some significant complications arise as a result of the nasogastric tube insertion. The patient 
experiences harm from this and it is considered a severe amount. Additional treatment is required 
and they require care in the Intensive Care Unit. Their condition deteriorates and they require 
surgery as a result. Ultimately they are treated successfully.  
Their mobility is limited as a result of these events and they require help for all activities.  
Discharge home will be significantly delayed. 
 



































Criteria for considering studies 
Types of studies  Observational  (chest x-ray) 
 Diagnostic test accuracy (pH testing)  
 Prospective or retrospective 
 Examining NGT placement confirmation; x-ray and/or pH testing 
Types of participants  Adult patients; defined through admission to an adult care area 
and/or not defined as paediatric by trialists 
 Hospital setting 
 Receiving general care; no artificial airway insitu  
Types of interventions  Short term NGT placement for any reason; defined as up to 6 weeks 
(NICE 2006) 
Table 1: criteria for considering studies for use in synthesis based estimates of effectiveness of both 
pH testing and chest x-ray 
 
Table 2 
Summary of effectiveness measure 






Low Harm  
Moderate 
Harm  
Severe Harm  Death  
Gharemani and 
Gould (1986)  
340 26 15 7 3 1 
Sorokin and 
Gottlieb (2006) 
2273* 23* 3* 5* 7* 8* 
de Aguilar-
Nascimento and 
Kudsk (2007)  
649* 10* 5* 3* 1* 1* 
Totals 3262 59 23 15 11 10 
Probability 
weights 
 0.018 0.39 0.25 0.19 0.17 
*indicates limited data set used from study to include only those patients without an artificial airway 
Table 2: Summary of effectiveness measures; chest x-ray  
 
Table 3 
Probability of obtaining aspirate for pH testing 
Source Number of attempts Aspirate obtained 
Kearns and Donna (2001) 380 365 
Metheny et al (1999) 511 460 
Neumann, Meyer and Dutton 
(1995) 
33 28 
Metheny et al (1989) 181 167 
Welch et al (1994)  106  35 
Totals 1211 1055 
Probability of obtaining aspirate  0.87 
  











Resource Amount Source 
NGT placement and confirmation 
Nursing time to pass NGT 12 minutes Patrick et al (1995)  
Nursing time for placement 
confirmation – pH testing  
2 minutes 
Kearns and Donna (2001)  
 Medical staff time for placement 
confirmation – chest x-ray   
51 minutes 
Complications - low 
No additional resource required   
Complications – moderate  
Additional nursing time (including 
care for increased acuity of 
patient and repeated checking 
procedures) 
24 hours 
Dickson and Mann (2011)  Additional medical staff time 
(including chest drain insertion 
and care for increased acuity of 
patient) 
12 hours 
Extended stay – ward bed 36 hours 
Complications – severe  
Additional nursing time  - ward 
based (including care for 
increased acuity of patient, 
repeated checking procedures 
and transfer to ITU) 
24 hours 
Lo et al (2008)  
Additional medical staff time – 
ward based (including chest drain 
insertion, care for increased 
acuity of patient and transfer to 
ITU) 
12 hours 
Extended stay – ward bed 3 days  
Extended stay – ITU bed 6 days 
Costs Amount Source and details  
NGT placement and confirmation 
Nursing time to pass NGT £3.52 Agenda for Change pay scale 
Band 5 (midpoint) 2012/13 pay 
rates  
Nursing time for placement 
confirmation – pH testing  
£0.59 
Medical staff time for placement 
confirmation – chest x-ray   
£23.81 Department of Health basic pay 
grade 3 (midpoint) for SHO 
Service of Hospital and Public 
Health Medical and Dental Staff 
and Community Doctors 2012/13 
at x 1 hourly rate 
First chest x-ray £56.13 ISD Scotland (2012)  
Radiology services tariff 
pH test consumables (including 
cost of syringe for aspiration and 
pH paper)  
£0.29 BD 10ml luer lock syringe x 1 
pH paper x 1 test from 160 pack 
Complications - low 
No additional costs required   
Complications – moderate  
Additional nursing time  £421.92 Agenda for Change pay scale 
Band 5 (midpoint) 2012/13 pay 
rates  




Additional medical staff time  £285.72 Department of Health basic pay 
grade 3 (midpoint) for SHO 
Service of Hospital and Public 
Health Medical and Dental Staff 
and Community Doctors 2012/13 
at x 12 hourly rate 
Extended stay – ward bed £382.50 Department of Health (2012) 
Reference costs for excess bed 
stay x 1.5 days  
Chest drain insertion  £1306 ISD Scotland (2012b)  
National Tariff input for  non-
elective minor thoracic 
procedures  
Repeat chest x-ray x 2 (pre and 
post chest drain insertion) 
£112.26 ISD Scotland (2012b)  
Radiology services tariff x 2 
Repeat pH test consumables  £0.29 As above 
Complications – severe  
Additional nursing time  - ward 
based  
£421.92 
As above  
Additional medical staff time – 
ward based 
£285.72 
Extended stay – ward bed £765 Department of Health (2012) 
Reference costs for excess bed 
stay x 3 days  
Extended stay – ITU bed £12384 ISD Scotland (2012b)  
National Tariff input for  critical 
care service ITU per day x 6   
Repeat chest x-ray x 3 (pre and 
post chest drain insertion, post 
ETT insertion) 
£168.39 ISD Scotland (2012b)  
Radiology services tariff x 3 
Chest drain insertion  £1306 ISD Scotland (2012b)  
National Tariff input for  non-
elective minor thoracic 
procedures  
Repeat pH test consumables  £0.29 As above 
Summary costs 
pH 
No complications 4.40 
Low complications 4.40 
Moderate complications 2513.09 
Severe complications 17136.77 
X-Ray 
No complications 83.64 
Low complications 83.64 
Moderate complications 2596.44 
Severe complications 17220.12 
Cost per positive repeat x-ray   
2nd x-ray £88.98 
3rd x-ray £89.51 
4th x-ray £88.98 
 
Table 4: Cost and resource inputs including summary estimates of costs of placement confirmation, 
complications and repeated chest x-rays 
  
 





 Health state 1 
No complications 
Health state 2 
Low complications 
Health state 3 
Moderate 
complications 
Health state 4 
Severe 
complications 
Summary EQ-5D index values 
Mean 0.897 0.672 0.491 0.109 
SE 0.042 0.018 0.036 0.025 
Median 1.00 0.678 0.523 0.036 
25th  0.796 0.592 0.378 0.036 
75th 1.00 0.7365 0.592 0.167 
Summary – EQ5D VAS values 
Mean 0.910 0.759 0.599 0.440 
SE 0.009 0.017 0.024 0.022 
Median 0.9 0.75 0.63 0.4 
25th  0.9 0.7 0.5 0.35 
75th 0.95 0.85 0.7 0.5 
Health state index conversion to QALY value 
QALY = utility value of health state x length of time in health state 
Mean 0.112 0.084 0.061 0.014 
Median 0.125 0.085 0.065 0.005 
25th  0.01 0.074 0.047 0.005 
















































ICER (cost per 
QALY gained, 
£) X-ray 
Base case 43.20 0.11 392.73 158.64 0.12 1322.00 
Effectiveness 
Aspiration success rate 
0.33 success 
(Welch et al 1994) 
19.12 0.04 478.00 158.64 0.12 1322.00 
0.93 success 
(Metheny et al 1989) 
45.88 0.12 382.33 158.64 0.12 1322.00 
pH confirmation rate 
0.803 (lower CI of 
meta-analysis) 
45.53 0.11 413.91 158.64 0.12 1322.00 
0.843 (upper CI of 
meta-analysis) 
40.88 0.11 371.64 158.64 0.12 1322.00 
Chest x-ray complication rate 
0.076 (Gharemani 
and Gould 1986) 
77.80 0.11 707.27 383.11 0.12 3192.58 
0.010 (Sorokin and 
Gottlieb 2006) 
38.43 0.11 349.36 127.68 0.12 1064.00 
Utility 
25th percentile  43.20 0.11 392.73 158.64 0.12 1322.00 
75th percentile  43.20 0.12 360.00 158.64 0.12 1322.00 
Mean utility  43.20 0.11 392.73 158.64 0.12 1322.00 
VAS utility 
(median) 
43.20 0.10 432.00 158.64 0.11 1442.18 
Cost 
Cost of death = 
severe 
complications 
55.66 0.11 506.00 210.89 0.12 1757.42 
 
Table 5: Base case cost utility results and sensitivity analyses 
 
 
 
